Evanston, IL, United States of America

Henry T Gaud

This inventor holds 4 USPTO granted patents. Top assignees: G.d. Searle & Company, Pfizer Corporation, Pharmacia Corporation. Active years: 2002-2010.


% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Henry T. Gaud

Introduction

Henry T. Gaud is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of complex compounds. With a total of 4 patents to his name, Gaud's work has had a lasting impact on various applications in the pharmaceutical industry.

Latest Patents

Among his latest patents, Gaud has developed a process for the qualitative preparation of 3-haloalkyl-1H-pyrazoles. This innovative synthesis of diaryl pyrazoles is designed for efficient, high payload commercial applications. His work in this area showcases his expertise and commitment to advancing chemical processes.

Career Highlights

Throughout his career, Gaud has worked with prominent companies such as G.D. Searle & Company and Pharmacia Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development projects.

Collaborations

Gaud has collaborated with several talented individuals in his field, including William D. McGhee and Leo J. Letendre. These partnerships have fostered a creative environment that has led to innovative solutions and advancements in their respective areas of expertise.

Conclusion

Henry T. Gaud's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the pharmaceutical industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…